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A relationship between the heat-labile (L) and heat-stable (S)  soluble anti- 
gens of vaccinia has been  shown to  exist by several workers.  Craigie and 
Wishart (1) originally regarded the two antigens as occurring in the form of a 
complex which elicited two separate antibodies in animals.  They were led to 
this conclusion because both antigens regularly are found in equal amounts in 
filtrates of infected tissue and because absorption with either specific antibody 
removes both serologically active substances.  Parker (2) observed that under 
certain conditions different results were obtained, e.g.,  a  solution containing 
both precipitable substances when treated with S-antibody lost its S-antigen 
but retained some L-antigen.  Craigie and Wishart (3),  at about this time, 
made similar observations; they reaffirmed that L-antigen ordinarily occurs 
in a  state of combination with S-antigen but reported  that with prolonged 
storage in the cold "this combination may dissociate into separate L  and S 
fractions prior to ultimate inactivation of the L antigen."  The data of Parker 
and of Craigie and Wishart that suggested dissociation of L- and S-antigens 
have not been duplicated in our laboratory.  This failure we believe indicates 
that conditions for successful repetition of such experiments occur infrequently. 
That they do occur occasionally we have no doubt, for, as will be shown in a 
subsequent paper  (4),  a  solution with L-activity only can be prepared from 
pure LS-antigen by enzymatic digestion. 
In our experience, L-antigen has always been encountered in association with 
S-antigen except under the special circumstances just mentioned.  This was 
true even though at various times during the past five years we have thought of 
the L-reacting substance as a protein, a carbohydrate, a fat, or a polypeptide 
and  have  attempted  to  isolate such  an  hypothetical material  from dermal 
filtrates by appropriate methods.  When it became evident that the methods 
employed were inadequate to procure preparations of L-antigen which were 
free of S-antigen for comparison with the relatively pure S-protein of Parker 
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and Rivers (5), other means were sought for the study of the relationship of 
these two antigens of vaccinia. 
The inhibition technique used  in serological work assisted  in establishing 
the existence of partially degraded forms of the A and B antigens of infectious 
myxomatosis  of  rabbits  (6).  These  two  protein-like  antigens  readily  lose 
their specific precipitability on gentle heating or even on storage.  Solutions 
of A-antigen, which are no longer capable of precipitating with A-antibody, 
still combine with it as demonstrated by the inhibition technique.  Solutions 
of degraded B-antigen behave similarly.  Inhibition by the non-precipitable A- 
and B-antigens is specific, i.e., each antibody combines only with the degraded 
form of its own antigen.  In view of the results obtained with myxoma anti- 
gens, inhibition of the L- and S-antibodies of vaccinia was investigated with the 
hope of demonstrating serologicaUy degraded forms of the L- and S-antigens. 
It was  thought  that  experimentation with  such  degraded  substances  might 
provide data which would help in interpreting the interrelationship of the two 
native antigens.  The results of these investigations are reported in this paper. 
Materials  and  Methods 
Source  of Soluble Antigens.--Dermal  filtrate  containing the  soluble  antigens  ot 
vaccinia was obtained from dermal pulp of rabbits which had been cutaneously in- 
fected 3 days previously with the CIL. strain of vaccine virus (1).  The pulp from 
each rabbit was suspended in 30 to 40 ec. of a 1:50 dilution of disodium phosphate- 
citric acid buffer solution,  pH 7.2.  The suspension was freed of gross particles and 
of essentially  all of the elementary bodies of vaccinia  by differential  centrifugation, 
and, finally, filtered through a Seitz pad to remove all residual virus.  These filtrates 
were  stored  at  3°C.  until  used. 
Antisera.--L-antiserum was prepared by absorbing  S-antibody from hyperimmune 
antivaccinal serum.  Vaccine  virus immune rabbits which had been given a  course 
of intravenous injections of active elementary bodies of vaccinia  provided the hy- 
perimmune serum; absorption of S-antibody was carried out with proper amounts of 
heated dermal filtrate.  S-antisera  were  obtained from non-immune  rabbits after 
several courses of injections of heat-inactivated elementary bodies. 
Precipitin  Tests.--0.25 cc. volumes  of serial dilutions of solution  of antigen were 
prepared in physiological saline solution buffered at pH 7.2 and mixed with 0.25 cc. 
amounts of an appropriate dilution of antiserum.  Readings were made after incuba- 
tion overnight in closed tubes held at 50°C. 
EXPERIMENTAL 
General Properties of L-Antigen.--Only  a  few procedures have been found 
practicable for the concentration of L-antigen from filtrates of dermal pulp 
obtained from rabbits  infected with  the  virus  of vaccinia.  These methods 
are equally efficacious for the concentration of S-antigen.  Craigie and Wishart 
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from virus-free dermal filtrate by bringing the pH of the solution to 4.5 and then 
redissolving the insoluble material thus obtained at pH 6.6.  In our hands this 
method has proved the simplest and the most satisfactory for obtaining solu- 
tions  containing large amounts of L- and  S-antigens from which have been 
eliminated  appreciable  amounts  of  serologically  inert  material.  Moderate 
variations  in the pH ranges employed for precipitating  and for redissolving 
the antigens still result in final solutions with equal amounts of the two serologi- 
cally active substances; in some instances, however, the recovery of antigenic 
material  is  less  complete than  it  is with  Craigie  and  Wishart's  technique. 
Bringing the pH to below 4.0 results in a loss of precipitability of L with its 
antibody, but S-activity is not appreciably reduced even at pH 1.8.  On the 
alkaline side of neutrality both serological substances retain their activity for 
many days in the cold at pH 9.0.  Furthermore,  the L-antigen is unaffected 
by short exposure to borate buffer of pH 11.0, while the S-antigen is inactivated 
in N/20 NaOH only after minutes or hours depending on whether the procedure 
is carried out at 56°C. or at 3°C.  Treatment with N/20 NaOH rapidly destroys 
the precipitability of L-antigen. 
Under the proper conditions, precipitation of concentrated unheated dermal 
filtrate with ammonium sulfate yields equal quantities of L- and S-antigen in 
the globulin fraction.  L-activity is generally lost during fractional precipita- 
tion with ammonium sulfate unless filtrates which have been concentrated 10 
to 20 times by evaporation are used as starting material; preliminary concen- 
trations of dermal filtrate is unnecessary, however, if the objective is purifica- 
tion of S-antigen.  Evaporation of dermal filtrate through cellophane sausage 
casings  suspended in an air stream at  room  temperature  provides  a  ready 
means of concentrating  the soluble antigens,  but fails to eliminate any sig- 
nificant amount of serologically  inert substances.  On the other hand, drying 
large volumes of dermal filtrate  from the  frozen  state  renders  some of the 
inert material insoluble on subsequent resuspension.  Although laborious, this 
procedure can be employed for concentration of the S-antigen,  but it is often 
unsatisfactory for work with L-antigen since  temporary thawing during  the 
process may be followed by partial or complete loss of L-precipitability. 
The boiling of solutions containing antigens of vaccinia at pH values near 
neutrality with subsequent removal of coagulated protein has been found by 
several workers (5, 7, 8) to be of assistance in the partial purification of solu- 
tions of the heat-stable antigen, but obviously this procedure has no place in 
experiments designed for the purification of the heat-labile material.  Similarly, 
treatment of dermal filtrate with large volumes of cold alcohol results in com- 
plete disappearance of the substance capable of precipitating with L-antibody 
even though the stable antigen  can be recovered from the alcohol insoluble 
fraction as has been demonstrated by others (5,  8). 
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properties in common with S-antigen.  Both are insoluble in the neighborhood 
of pH 4.5 and soluble in the region of pH 6.5, and both are found in the globulin 
fraction when separated from concentrated dermal filtrate by partial satura- 
tion with ammonium sulfate.  The heat-labile antigen, however, readily loses 
its specific  precipitability under conditions which do not alter the heat-stable 
antigen, v/z., extremes of pH, treatment with alcohol, and, in certain instances, 
drying from the frozen state  or precipitation with ammonium sulfate.  The 
common solubilities of the two antigens give no clue to their nature, since the 
data might equally well suggest that the antigens are parts of a single  protein 
molecule, or that they are similar protein substances, or that L is a  non-protein 
material associated with the S-protein molecule. 
Inhibition  of L-Antibody 
Solutions containing both L- and S-precipitable substances in high concen- 
tration showed no change in physical appearance when heated at  56°C. for 1 
hour.  This led us to think that the L-antigen, which was no longer demon- 
strable  by the usual precipitation  technique,  might still  be present  in  these 
heated solutions in an altered form which was unable to precipitate with L- 
antibody.  It seemed possible, furthermore, that such an altered antigen might 
inhibit L-antibody, and,  indeed,  this was found to be the case as shown by 
the  following experiment. 
Experiment 1.--1500  cc. of dermal  filtrate  were placed  in  cellophane  tubes  and 
concentrated  to 100 cc. by evaporation.  The material  was dialyzed against  running 
water overnight, and while still in the original cellophane tube was again concentrated 
by evaporation  to 50 cc.  This solution reacted in a dilution of 1 : 1024 with optimal 
amounts  of both L- and  S-antibodies.  Globulin  material  was obtained  from  the 
concentrate  by fractional precipitation  with ammonium sulfate.  50 cc. of a solution 
of the reprecipitated  globulin material  were treated with 5 cc. of standard citric acid- 
disodinm  phosphate  buffer, pH  4.5.  Most of  the  material  insoluble  under  these 
conditions redissolved when taken up in 20 cc. of diluted buffer solution, pH 6.6.  This 
solution, containing  globulin material insoluble at pH 4.5 and soluble at pH 6.6, had 
as much L- and  S-activity as  did the original  concentrated  dermal  filtrate.  After 
heating  at  56°C. for  1 hour the  solution  no longer precipitated  with L-antiserum 
but its titer with S-antiserum  was not reduced.  One cc. of the heated  solution was 
added to an equal  amount of undiluted  L-antiserum;  the mixture  was diluted  with 
4 cc. of saline solution, incubated at 56°C. for 1 hour, and stored at 3°C. for 24 hours. 
No precipitate  appeared.  This  treated mixture,  which should have contained  suf- 
ficient L-antibody to react strongly with  unheated L-antigen,  failed to form a  pre- 
cipitate when added to serial dilutions of unheated dermal filtrate and incubated under 
the usual conditions.  The inhibition  experiment  was repeated  with identical  results 
when portions of the same solution of antigen  which had been heated at 60°C., 80°C., 
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In  the  experiment  just  described  L-antigen  in  the  concentrated  globulin 
material from dermal filtrate was affected in the usual manner by heating, i.e., 
it  no  longer  precipitated  with  L-antibody.  A  substance  was present,  how- 
ever, in the heated solutions which was capable of inhibiting in some way the 
flocculation  of  L-antibody  with  unheated  L-antigen.  Since  the  partially 
purified  material  employed  in  the  experiment  was  highly  concentrated,  it 
seemed desirable to repeat the inhibition procedure with a  more dilute solution. 
For this purpose crude dermal filtrate prepared  according to routine was used. 
Experiment 2.--Dermal  filtrate,  pool 6, which precipitated in a dilution of 1 : 128 
in the presence of optimal amounts of either L- or S-antibody was heated in a closed 
flask in a water bath at 80°C.  for 1 hour.  The heated filtrate which no longer pre- 
TABLE I 
Inhibition of L-Antibody by HeaSed Dermal Filtrate 
Antigen 
Dermal filtrate 6 
(untreated) 
Treatment of L-antiserum 
6814" 
Control 
1 volume  heated  vac- 
cinia dermal filtrate 
3 volumes heated vac- 
cinia dermal filtrate 6 
5 volumes heated vac- 
cinia dermal filtrate 
5 volumes heated myx- 
oma dermal filtrate 
1:8 
++-I- 
++ 
+++-4- 
Dilution of antigen 
1:16 
++++ 
++++ 
++++ 
1:32  1:64 
++++  +++ 
+++  ± 
++++  +++ 
1:128  1:256 
.-~- 
-- 
* Dilution of antiserum  was 1 : 8 in each test. 
cipitated  with L-serum was added in varying amounts  to 0.5  cc.  portions  of  un- 
diluted L-antiserum.  Sufficient saline solution was added to each mixture to bring 
the final dilution of serum to 1 : 8 and the mixtures were incubated at 56°C. for 1 hour. 
Samples of the treated serum, together with a control serum diluted only with saline, 
were tested for their capacity to precipitate with serial dilutions of unheated dermal 
filtrate,  pool 6.  The results,  summarized in Table I, show that the addition of an 
equal volume of heated filtrate  to L-antiserum appreciably decreased the power of 
the serum to react with unheated filtrate.  Furthermore,  no precipitation  occurred 
when the serum mixtures containing 3 and 5 volumes, respectively, of heat-inactivated 
filtrate were tested against solutions known to possess  active L-antigen. 
The data obtained in Experiments  1 and 2 indicate that crude or partially 
purified  solutions  containing either  small  or large amounts  of L- and  S-sub- 
stances  lose their  capacity to precipitate  with L-antibody after heating,  but 
are,  nevertheless,  still  able  to inhibit  L-antibody. 
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served by others.  Craigie and Wishart  (1)  found that  certain heated crude 
dermal filtrates employed for absorption studies with antivaccinal serum con- 
tained inhibiting substances which were carried along with the absorbed serum 
and  subsequently  interfered  with  the  demonstration  of residual  antibodies. 
These authors regarded the inhibitory substances as non-specific in character 
and  found  that  fractionation  of  the  filtrates  resulted  in  their  elimination. 
Salaman  (9)  likewise observed reductions  in precipitin and  agglutinin  titers 
following absorption of antiserum with  large amounts  of dermal filtrate;  he 
regarded these effects as examples of the familiar inhibition which occurs in 
the presence of an excess of antigen and thought that they should not be called 
non-specific.  Since  the  L-antigen  had  been  rendered  non-precipitable  by 
heating,  the  inhibition  of L-antibody observed in  Experiments  1 and  2 was 
certainly not dependent upon the presence of an excess of precipitable L-anti- 
gen.  Moreover, that the inhibition was serologically specific was demonstrated 
in the following manner. 
Experiment 3.--Dermal filtrate was prepared from rabbits cutaneously infected 
with the virus of myxomatosis by a technique essentially identical with that employed 
for rabbits infected with vaccinia.  The filtrate which was rich in the A and B soluble 
antigens of myxoma was heated at 56°C. for 1 hour and then mixed with antivaccinal 
serum.  The mixtures were tested for L-precipitins of vaccinia in the usual manner. 
As indicated by the results summarized in Table I, no inhibition of L-antibody oc- 
curred even when 5 volumes of the myxomatous filtrate were added to the L-antiserum. 
It has already been recorded that vaccine dermal filtrate fails  to inhibit  the anti- 
soluble substance antibodies of myxomatosis (6). 
Heated  dermal  filtrate  appeared  to  be  capable  of  specifically  inhibiting 
L-antibody of vaccinia.  It will be recalled that L-antisera are regularly pre- 
pared  by  absorbing  hyperimmune  antivaccinal  serum  with  heated  dermal 
filtrate; this absorption procedure when carried out under the proper conditions 
removes  S-antibody  and  leaves  L-antibody.  This  apparent  contradiction 
was shown  to  depend  on  a  quantitative  factor;  a  much  smaller amount  of 
heated filtrate was generally needed to absorb S-antibody from immune serum 
than  was necessary to  obtain  demonstrable inhibition  of L-antibody. 
Experiment 4.--Unabsorbed  hyperimmune  serum,  number  6814, reacted  in  a 
dilution of 1:32 with an optimal amount of unheated filtrate, pool 6, and in a dilution 
of 1:4 with heated filtrate.  Complete removal of S-antibody without a detectable 
reduction in the quantity of L-antibody resulted when the hyperimmune serum was 
absorbed with an equal volume of a  1:8 dilution  of dermal filtrate, pool 6,  which 
had been heated at 80°C. for 1 hour.  L-precipitins, however, were no longer demon- 
strable in  this  antiserum after it  was treated  with an equal volume of four-times 
concentrated solution  of heated filtrate, pool 6.  The filtrate had been concentrated 
by evaporation in a cellophane  bag.  Results of this experiment are summarized in 
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The  material having  the property of inhibiting L-antibody in  the  experi- 
ments  so far  presented  always  occurred  in  association  with  S-antigen.  It 
seemed desirable, therefore,  to prepare purified S-antigen by the method  of 
Parker and Rivers (5) and to test the power of this substance to block or in- 
hibit  L-antibody. 
Experiment 5.--625 cc. of dermal filtrate, pool 7, having a titer of 1 : 128 with optimal 
dilutions of L- and S-antisera were boiled and subsequently the globulin fraction was 
salted out with ammonium sulfate.  The redissolved globulin fraction was precipitated 
with alcohol, redissolved in water, precipitated at pH 4.6 with citric acid-disodium 
phosphate buffer solution, and, finally, redissolved in dilute citric acid-disodium phos- 
phate buffer solution, pH 8.0.  This solution was boiled, the pH was then changed to 
TABLE II 
Preparation of L-Serum  by Absorption  of Immune Serum  with Heated Dermal Filtrate and 
Inhib4tion of L-Antibody  with the Same Material 
Hyperimmune 
serum 6814 
Untreated 
Absorbed* 
Inhibited~ 
Antigen: 
Dermal filtrate6 
diluted 1:16 
Unheated 
Heated 
Unheated 
Heated 
Unheated 
1:2 
++++ 
++-b+ 
Dilution of serum 
1:____5__* 
+-b-b+ 
++ 
++++ 
1:8 
-k+++ 
+-b-b+ 
1:16 
++++ 
++++ 
1:32 
++++- 
]+-t--t-+- 
1:64 
? 
? 
1:128 
* Absorbed serum was prepared by treating 1.5 cc. of serum  6814 with 1.5 cc. of a  1:8 
dilution of heated dermal filtrate 6. 
~; Inhibited serum was prepared by treating 6814 with an equal volume of 4 X concentrated 
solution of heated dermal filtrate 6. 
6.0  by the addition of sodium hydroxide, the  solution was again boiled, and  then 
dialyzed free of salts.  0.25 cc. of a  1 : 1024 dilution of this final solution gave a pre- 
cipitate with optimal amounts of S-antibody.  A portion of the 41 cc. of final solution 
was dried from  the frozen state and  the  residue was weighed; the solution before 
drying was shown to have contained 5.1 mg. of dry material per cc.  Hence, on the 
basis of precipitin titer and dry weight, it was estimated that 1 part in 800,000  was 
sufficient to give a  specific reaction with  S-antiserum.  The  relative purity of the 
final preparation appeared to be of the same order as that obtained by Parker and 
Rivers.  Portions of the final preparation of S-antigen as well as samples of different 
fractions obtained during the process of purification were tested in the usual way for 
their inhibitory effect on 0.5 cc. volumes of L-antiserum, number 6814.  The results 
are summarized in Table III. 
The results summarized in Table III show that the substance in crude vaccine 
dermal filtrate capable of inhibiting L-antibody was also present in materials 158  LS-ANTIGEN OF  VACCINIA 
obtained at  intermediate stages and  in  the final stage of the purification of 
S-antigen.  These data indicate that L-inhibitor, like the precipitable form of 
L-antigen, is closely associated with  S-antigen. 
Inhibiti~m  of S-Antibody 
Earlier observations  (10)  indicated that  S-antigen which  has  been  heated 
with dilute alkali is not precipitated by its antibody.  The capacity of such a 
degraded antigen to combine with  S-antibody was investigated by means of 
the  inhibition technique.  The  following protocol  illustrates  the  results  ob- 
tained  in  a  typical experiment. 
Experiment  6.---40 rag. of the final dried preparation of S-antigen from Experiment 
5 were dissolved in 8 cc. of N/20 NaOH.  The solution remained clear after heating 
TABLE III 
Inhibition of L-Antibody by a Preparation of S-Antigen 
Antigen 
Dermal fil- 
trate 
Fraction prepared  from heated 
dermal filtrate 
Globulin fraction 
Alcohol  insoluble frac- 
tion of globulin 
Final solution  of S-an- 
tigen 
L-antiserum 
treated wlth 
fraction 
None 
I volume 
i  " 
1  " 
2 volumes 
Dilution  of untreated dermal  filtrate 
1:8 
+++ 
++ 
1:16  1:32  1:64 
!+++-~  ++++  +++ 
++  ÷  - 
1:128 
+ 
Dilution of L-antiserum was 1 : 6 in all tests.  Inhibited sera were obtained by adding 1 or 
2 volumes of test material to 0.5 cc. amounts of L-antiserum.  S-antigen titer of each test 
material was 1 : 1024.  Final solution of S contained 5 rag. per cc. 
at 56°C. for 90 minutes.  A faint opalescence which appeared when the treated solu- 
tion was brought to pH 7.2 with N/1  HC1 was eliminated by ultracentrifugation at 
30,000  R.~.M.; the  small amount  of sediment thus  obtained was  discarded.  Serial 
dilutions of the clear supernatant fluid which contained practically all of the degraded 
S-antigen  did not  form  precipitates when  incubated  with  optimal amounts  of  S- 
antibody.  Varying  quantities  of  the  undiluted  solution  of  treated  antigen  were 
mixed with 0.4 cc. volumes of S-antiserum, number 274, and with 0.3 cc. volumes of 
L-antiserum, number 6814;  sufficient saline solution was added to each mixture to 
bring the final concentrations of antisera to their optimal dilutions.  The mixtures, 
all of which remained clear after incubation at 56°C. for 1 hour, were tested for demon- 
strable precipitins against L- and S-antigens by the usual methods.  The results are 
summarized in Table IV. 
The data presented in Table IV indicate that S-antigen of vaccinia which has 
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its antibody is still able to combine with this antibody.  For example, 0.5 mg. 
of treated antigen completely inhibited the antibody in 0.4 cc. of undiluted 
S-antiserum.  It  is  also  evident that this preparation of degraded antigen 
had only a slight capacity to inhibit L-antibody.  That the property of the 
degraded S-antigen  to inhibit L-antibody was  indeed  less  than that of the 
purified  precipitable  S-antigen  from which  it was  derived may be  seen  by 
comparing the data given in the protocols of Experiments 5 and 6; for instance, 
2 to 3 times as much of the alkali-treated  material was needed to produce 
the slight inhibitory effect on L-antibody observed  in  Experiment 5 where 
undegraded S-antigen  was  used. 
TABLE IV 
InMMtion of S-A ntibody 
Antigen 
Dermal fil- 
trate 
Antiserum 
S 
(diluted 1:4) 
L 
(diluted 1:6) 
Treatment of 
antiserum with 
degraded S 
rag. 
None 
0.125 
0.25 
0.50 
0.75 
1.00 
None 
1.00 
7.50 
1:8 
+++- 
+++ 
? 
+++ 
++++ 
+++ 
Dilution of antigen 
1:16 
++++ 
++++ 
+++ 
++++ 
++++ 
++ 
1:32 
++++ 
++++ 
++++ 
++++ 
++++ 
++ 
1:64 
++++ 
++++ 
+ 
++++ 
+++ 
1:128 
++ 
++ 
++ 
+ 
0.4 cc. volumes of S-antiserum and 0.3 cc. volumes of L-antiserum were treated with the 
designated amount of S-antigen which had been heated at 56°C. for 90 minutes in the presence 
of  N/20 NaOH. 
Inhibition of S-antibody can also be demonstrated by adding the antibody 
directly to mixtures of native and degraded S-antigen.  In this type of ex- 
periment, however,  the latter material must be present in large amounts in 
comparison to the former.  This is illustrated by the data presented in Table V 
which summarizes the results obtained when alkali and heat-treated S-antigen 
from Experiment 6 was added in increasing  amounts to 0.4  cc. volumes of 
unheated dermal filtrate, after which serial dilutions of the mixtures were pre- 
pared and incubated  with  optimal  amounts of  L- or S-antibody.  Results 
of the titrations made with the mixture containing 0.1  mg.  of degraded S- 
antigen were comparable to the controls.  The presence of 1.0 mg. of the non- 
precipitable or degraded antigen prevented flocculation of the native S-antigen 
only in the lowest dilutions of the titrations with S-antibody, while 5.0  rag. 
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out the range of dilutions.  In none of the mixtures was the reaction with  L- 
antibody appreciably altered. 
On  several  occasions  S-inhibitor  has  been  encountered  in  preparations  of 
vaccine  dermal  filtrate  that  were  not  subjected  to  alkaline  treatment.  In 
these experiments the filtrates were concentrated 10 to 20 times before  boiling. 
The technique for purifying S-antigen was originally applied  to crude dermal 
filtrates  (5).  In order to avoid working with large  volumes, we first concen- 
trated the crude filtrates by evaporation in cellophane tubes.  The results ob- 
tained when the purification procedure was applied to these concentrates were 
disappointing in that yield of S-antigen was negligible as determined by pre- 
TABLE V 
Inhibition of S-Atalbody----Cont~nued 
Antigen mixture 
Dermal  filtrate 
0.4 
0.4 
0.4 
0.4 
Degraded 
S-antigen 
~g. 
0.1 
1.0 
2.0 
5.0 
Antiserum 
L 
S 
L 
S 
L 
S 
L 
S 
1:8 
4.4.÷4. 
4.+4.4. 
4.4.++ 
4.4.4.4- 
4-+4-4- 
Dilution of original dermal filtrate 
1:16  1:32 
+4-+4.  4.+4.4- 
4-+4-4-  4-++4. 
+4.4.4-  4-++ 
4-4-4-4-  4-4-4-+ 
+4.4.4.  4.+4- 
++4.+  +++ 
1:64 
++ 
+++ 
++ 
4-++ 
4-4- 
4-+ 
4- 
Mixtures of dermal filtrate  and degraded  S-antigen were incubated  at 37°C. for 1/~ hour 
and then diluted serially.  Constant amounts of L-antiserum  6814 diluted  1:6 and of S-antP 
serum 274 diluted  1:4 were added and the titration results were read after incubation over- 
night at 50°C. 
cipitin tests.  The failure  to  demonstrate  the expected amounts of S-antigen 
in the solutions was found to be  dependent upon the presence of an inhibitor 
which could be removed, leaving behind precipitable  S-antigen.  The results 
of this type of work are illustrated  by the following experiment. 
Experiment 7.--960 cc. of dermal filtrate, pool 8, were dialyzed in cellophane tubes 
against running water and then concentrated to 90 cc. in the same tubes by evapora- 
tion in a stream of air.  The clear solution became opalescent after gentle boiling for 
5 minutes, and the small amount of precipitate that formed was removed by centrif- 
ugation.  The  globulin  fraction obtained by precipitation  with ammonium sulfate 
was redissolved in water, dialyzed free of sulfate ions, and brought back to a  volume 
of 90 cc.  The original crude dermal filtrate in a  dilution of 1:64 precipitated  with 
L- and S-antisera, but the concentrated solution of heated globulin gave only a slight 
precipitate in dilutions of 1:8 to 1:32 with S-antiserum.  A portion of the solution j.  E.  SMADEL AND T.  M.  RIVERS  161 
of globulin  was fractionated by the method of Craigie  and Wishart (1) for the con- 
centration of LS-antigen.  Only about half of the voluminous white precipitate ob- 
tained at pH 4.5 redissolved  when it was suspended  in buffer solution,  pH 6.6.  The 
solution containing the material which  dissolved  at pH 6.6 had a precipitin titer of 
1:128 when tested with S-antiserum.  The material which failed to dissolve at pH 6.6 
was soluble  in dilute buffer solution,  pH 9.0, and the solution  remained clear when 
brought back to pH 7.0.  While  this solution  did not precipitate in dilutions  of 1:4 
to 1:512 in the presence of an optimal amount of S-antibody, it was found to have a 
marked inhibiting effect on S-antibody.  S-antiserum treated with 3 volumes of the 
solution would not precipitate with native S-antigen.  On the other hand, L-antiserum 
was not appreciably inhibited by 5 volumes of the solution. 
The results obtained in Experiment 7 throw some light on the work of Craigie 
and Wishart (1).  For example, it was shown that under certain conditions the 
heating of dermal filtrate,  even in the pH range near neutral reactions, may 
result  in  the  formation  of  S-inhibitor.  Furthermore,  it  was  found  that  S- 
inhibitor can be separated from precipitable S-antigen by means of the different 
solubilities  of  the  two  substances  at  several pH values. 
DISCUSSION 
The  results  of  the  foregoing  experiments  may  be  briefly  summarized  as 
follows.  Dermal filtrate prepared from the skin of rabbits infected with the 
virus of vaccinia contains the heat-labile  (L) and heat-stable (S)  antigens of 
vaccinia which  can be demonstrated by the precipitation technique.  Gentle 
heating destroys the precipitability of L-antigen but leaves in solution a  sub- 
stance  capable of inhibiting L-antibody.  This L-inhibitor,  like precipitable 
L-antigen, is closely associated with S-antigen and cannot readily be separated 
from it.  Preparations  of S-antigen  can also be degraded  by any of several 
methods to a  stage where precipitation with S-antibody does not occur; how- 
ever, inhibition of S-antibody with this material is easily demonstrated.  De- 
graded  S-antigen,  in  contrast  to  precipitable  S-antigen,  has  little  power  to 
inhibit  L-antibody.  The  solubilities  of  S-inhibitor  are  different  from those 
of S-antigen and L-inhibitor. 
The immediate objective of the present experiments, ~/z., the demonstration 
of degraded forms of L- and S-antigens of vaccinia which are capable of in- 
hibiting  their  specific  antibodies,  was  accomplished.  The studies were less 
successful, however, in regard to their ultimate objective which was the elucida- 
tion  of the  relationship  between  L- and  S-antigens.  Nevertheless,  the  ob- 
servations just reported may serve as the basis for several hypotheses on the 
relationship of these two serologically active substances. 
One of the simplest of the hypotheses is as follows: The native antigen pres- 
ent in infected tissue is L, or the antecedent substance from which it is derived. 
L  is readily degraded during manipulation and storage to a  slightly modified 162  LS-ANTIGEN  0]~  VACCINIA 
material, S, which is still capable of eliciting a specific antibody in animals and 
which  combines  with  L-antibody  as  demonstrated  by  inhibition  tests.  S- 
antigen  can be further degraded to a stage where it inhibits but fails to pre- 
cipitate with its antibody; and, in this form it loses most of its ability to com- 
bine  with  L-antibody.  A  graphic  representation  of  the  various  stages  of 
degradation according to this scheme is presented  in  Text-fig.  1.  There  are 
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several serious objections to this hypothesis.  No reasonable explanation is at 
hand for the regular occurrence of equal amounts of L- and S-antigen in prepa- 
rations from infected tissue.  Moreover, it should be possible, if the hypothesis 
were correct, to demonstrate a simultaneous increase in S along with a decrease 
in L  during the various procedures which render L-antigen non-precipitable. 
A second hypothesis might begin with the assumption that L- and S-antigens 
are separate protein molecules which are distinguishable by serological means 
but  not  by  ordinary  physical  and  chemical  procedures.  According  to  this 
idea each of the antigens could be degraded independently, but, since L is more j.  E.  SMADEL  AND  T.  M.  RIVERS  163 
easily affected than S,  the labile antigen would generally be  denatured one 
step further than the stable  one  (Text-fig. 1).  The  similar physicochemical 
nature of the native substances might also be considered to be characteristic 
of the mildly degraded antigens; thus, a separation of L-inhibitor and S-antigen 
would be difficult.  This hypothesis, like the first, affords no explanation for 
the uniform ratio of L- and S-antigens in crude filtrates.  Furthermore, it is 
hard to reconcile it with the almost invariable results obtained in absorption 
experiments, namely, the removal of both antigens on the addition of either 
antibody. 
A third hypothesis deals with an LS-complex similar to that postulated by 
Craigie and Wishart (1).  No assumptions need be made about the chemical 
nature of the L-part of this complex or about the type of union between it and 
the protein-like S-part.  As in the second hypothesis, the L-reacting substance 
would be considered to be degraded more readily than the S under ordinary 
conditions, and complexes might be formed of L'S and L"S' on treatment with 
heat or  heat and  alkali,  respectively  (Text-fig.  1).  In  such  a  scheme the 
first degradation product,  e.g.,  L ~ would  inhibit L-antibody but not be pre- 
cipitated by it, while L" would have lost most of its capacity to inhibit L-anti- 
body.  Similarly, stages in the degradation of the S-portion of  the complex 
could  be  postulated.  Additional  complexes  with  various  combinations  of 
native and degraded stages of the L- and S-parts might be considered; several 
of these are represented  in Text-fig.  1,  (a),  (b),  (c).  The objections raised 
to the first two hypotheses are not valid for the last one.  The unusual results 
of occasional absorption experiments reported by Parker (2) and Craigie and 
Wishart (3) can be explained by this hypothesis if one assumes that under cer- 
tain rare conditions a portion of the LS-complex in dermal filtrate is degraded 
to a form represented as LS' (Text-fig. 1, (c)).  A mixture of this complex and 
native LS when treated with S-antibody could result in the precipitation of LS, 
leaving in solution LS' combined with S-antibody.  Such a  soluble antigen- 
antibody combination might then be precipitated on the addition of L-antibody. 
At the time these experiments were completed we were inclined to accept 
the third hypothesis as the one which more nearly explained the available date 
on the relationship of the L- and S-antigens of vaccinia.  Work reported in 
accompanying and subsequent papers  (4,  11)  has done much to strengthen 
our belief that this hypothesis is substantially correct. 
CONCLUSION 
Experimental  data  are  presented  which  may  be  interpreted  as  follows. 
The heat-labile (L) and heat-stable (S) antigens of vaccinia occur in nature as 
a complex consisting of a single substance with two serologically active parts, 
each of which may be degraded independently of the other. 
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